Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2014 1
2016 1
2017 1
2018 2
2019 2
2020 1
2021 1
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment.
Drees EEE, Jauw YWS, van Dijk E, Borchmann S, Verkuijlen SAWM, Stathi P, Groenewegen NJ, Hijmering NJ, Berry DRAI, Meershoek EJ, Hoogmoed D, Kwakman A, Molenaar TJ, Pegtel DM, Ylstra B, de Jong D, Zijlstra JM, Roemer MGM. Drees EEE, et al. Among authors: jauw yws. Hemasphere. 2022 Jul 4;6(7):e749. doi: 10.1097/HS9.0000000000000749. eCollection 2022 Jul. Hemasphere. 2022. PMID: 35813096 Free PMC article. No abstract available.
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.
Eertink JJ, Zwezerijnen GJC, Wiegers SE, Pieplenbosch S, Chamuleau MED, Lugtenburg PJ, de Jong D, Ylstra B, Mendeville M, Dührsen U, Hanoun C, Hüttmann A, Richter J, Klapper W, Jauw YWS, Hoekstra OS, de Vet HCW, Boellaard R, Zijlstra JM. Eertink JJ, et al. Among authors: jauw yws. Blood Adv. 2023 Jan 24;7(2):214-223. doi: 10.1182/bloodadvances.2022008629. Blood Adv. 2023. PMID: 36306337 Free PMC article.
Noise sensitivity of 89Zr-Immuno-PET radiomics based on count-reduced clinical images.
Somasundaram A, García DV, Pfaehler E, Jauw YWS, Zijlstra JM, van Dongen GAMS, Menke-van der Houven van Oordt WC, Huisman MC, de Vries EGE, Boellaard R. Somasundaram A, et al. Among authors: jauw yws. EJNMMI Phys. 2022 Mar 3;9(1):16. doi: 10.1186/s40658-022-00444-4. EJNMMI Phys. 2022. PMID: 35239050 Free PMC article.
3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18F-Fluorodeoxyglucose and 89Zr-Rituximab PET Scans.
de Vries BM, Golla SSV, Zwezerijnen GJC, Hoekstra OS, Jauw YWS, Huisman MC, van Dongen GAMS, Menke-van der Houven van Oordt WC, Zijlstra-Baalbergen JJM, Mesotten L, Boellaard R, Yaqub M. de Vries BM, et al. Among authors: jauw yws. Diagnostics (Basel). 2022 Feb 25;12(3):596. doi: 10.3390/diagnostics12030596. Diagnostics (Basel). 2022. PMID: 35328149 Free PMC article.
Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake.
Wijngaarden JE, Huisman MC, Jauw YWS, van Dongen GAMS, Greuter HNJM, Schuit RC, Cleveland M, Gootjes EC, Vugts DJ, Menke-van der Houven van Oordt CW, Boellaard R. Wijngaarden JE, et al. Among authors: jauw yws. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):1897-1905. doi: 10.1007/s00259-023-06151-1. Epub 2023 Feb 23. Eur J Nucl Med Mol Imaging. 2023. PMID: 36820891 Free PMC article.
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET.
Wijngaarden JE, Jauw YWS, Zwezerijnen GJC, de Wit-van der Veen BJ, Vugts DJ, Zijlstra JM, van Dongen GAMS, Boellaard R, Menke-van der Houven van Oordt CW, Huisman MC. Wijngaarden JE, et al. Among authors: jauw yws. EJNMMI Res. 2024 Feb 15;14(1):18. doi: 10.1186/s13550-024-01079-5. EJNMMI Res. 2024. PMID: 38358425 Free PMC article.
19 results